mm1313亚洲精品,欧美俄罗斯40老熟妇,欧美日韩在线观看视频在线,亚洲欧美国产激情综合在线

掃碼關(guān)注公眾號(hào)           掃碼咨詢技術(shù)支持           掃碼咨詢技術(shù)服務(wù)
  
客服熱線:400-901-9800  客服QQ:4009019800  技術(shù)答疑  技術(shù)支持  質(zhì)量反饋  人才招聘  關(guān)于我們  聯(lián)系我們
夜鲁夜鲁很鲁视频在线观看,日韩高清视频一区二区
首頁(yè) > 新聞動(dòng)態(tài) > 正文
【7月文獻(xiàn)戰(zhàn)報(bào)】Bioss抗體新增高分文獻(xiàn)精彩呈現(xiàn)
發(fā)表者:北京博奧森生物      發(fā)表時(shí)間:2022-8-18


截止目前,引用Bioss產(chǎn)品發(fā)表的文獻(xiàn)共19603篇,總影響因子87327.086分,發(fā)表在Nature, Science, Cell以及Immunity等頂級(jí)期刊的文獻(xiàn)共53篇,合作單位覆蓋了清華、北大、復(fù)旦、華盛頓大學(xué)、麻省理工學(xué)院、東京大學(xué)以及紐約大學(xué)等國(guó)際知名研究機(jī)構(gòu)上百所。

我們每月收集引用Bioss產(chǎn)品發(fā)表的文獻(xiàn)。若您在當(dāng)月已發(fā)表SCI文章,但未被我公司收集,請(qǐng)致電Bioss,我們將贈(zèng)予現(xiàn)金鼓勵(lì),金額標(biāo)準(zhǔn)請(qǐng)參考“發(fā)文章 領(lǐng)獎(jiǎng)金”活動(dòng)頁(yè)面。

近期收錄2022年7月引用Bioss產(chǎn)品發(fā)表的文獻(xiàn)共247篇(圖一,綠色柱),文章影響因子(IF) 總和高達(dá)1703.345,其中,20分以上文章3篇,10分以上文獻(xiàn)39篇(圖二)。

圖一


圖二



本文主要分享引用Bioss產(chǎn)品發(fā)表文章至Nature NanotechnologyImmunityCancer Cell等期刊的8篇 IF>10的文獻(xiàn)摘要,讓我們一起欣賞吧。


Molecular Cancer [IF=41.444]

文獻(xiàn)引用抗體:bs-1152R

Anti-ATPase Na+/ K+ beta 2(Loading Control) pAb; WB

作者單位:美國(guó)紐約西奈山伊坎醫(yī)學(xué)院醫(yī)學(xué)系

摘要:Background

Long Interspersed Nuclear Element-1 (LINE-1, L1) is increasingly regarded as a genetic risk for lung cancer. Transcriptionally active LINE-1 forms a L1-gene chimeric transcript (LCTs), through somatic L1 retrotransposition (LRT) or L1 antisense promoter (L1-ASP) activation, to play an oncogenic role in cancer progression.

Methods

Here, we developed Retrotransposon-gene fusion estimation program (ReFuse), to identify and quantify LCTs in RNA sequencing data from TCGA lung cancer cohort (n?=?1146) and a single cell RNA sequencing dataset then...


Signal Transduction and Targeted 

Therapy [IF=38.104]

文獻(xiàn)引用抗體:bs-20694RAnti-Beta tubulin pAbIF

作者單位:中山大學(xué)生命科學(xué)學(xué)院

摘要:SARS-CoV-2, the culprit pathogen of COVID-19, elicits prominent immune responses and cytokine storms. Intracellular Cl? is a crucial regulator of host defense, whereas the role of Cl? signaling pathway in modulating pulmonary inflammation associated with SARS-CoV-2 infection remains unclear. By using human respiratory epithelial cell lines, primary cultured human airway epithelial cells, and murine models of viral structural protein stimulation and SARS-CoV-2 direct challenge, we demonstrated that SARS-CoV-2 nucleocapsid (N) protein could interact with Smad3, which downregulated cystic fibrosis transmembrane conductance regulator (CFTR) expression via microRNA-145. The intracellular Cl? concentration ([Cl?]i) was raised, resulting in phosphorylation of serum glucocorticoid regulated kinase 1 (SGK1) and robust inflammatory responses. Inhibition or knockout of SGK1 abrogated the N protein-elicited airway inflammation. Moreover, N protein promoted a sustained elevation of [Cl?]i by depleting intracellular cAMP via upregulation of phosphodiesterase 4 (PDE4). Rolipram, a selective PDE4 inhibitor, countered airway inflammation by reducing [Cl?]i. Our findings suggested that Cl? acted as the crucial pathological second messenger mediating the inflammatory responses after SARS-CoV-2 infection. Targeting the Cl? signaling pathway might be a novel therapeutic strategy for COVID-19.



Cell Stem Cell [IF=25.269]


文獻(xiàn)引用抗體:

bs-3155R;Anti-Phospho-GCN2 (Thr899) pAb

bs-2469R;Anti-PERK pAb

作者單位:中山大學(xué)中山紀(jì)念醫(yī)院RNA生物醫(yī)學(xué)研究所
摘要:Hematopoietic stem cells (HSCs) adapt their metabolism to maintenance and proliferation; however, the mechanism remains incompletely understood. Here, we demonstrated that homeostatic HSCs exhibited high amino acid (AA) catabolism to reduce cellular AA levels, which activated the GCN2-eIF2α axis, a protein synthesis inhibitory checkpoint to restrain protein synthesis for maintenance. Furthermore, upon proliferation conditions, HSCs enhanced mitochondrial oxidative phosphorylation (OXPHOS) for higher energy production but decreased AA catabolism to accumulate cellular AAs, which inactivated the GCN2-eIF2α axis to increase protein synthesis and coupled with proteotoxic stress. Importantly, GCN2 deletion impaired HSC function in repopulation and regeneration. Mechanistically, GCN2 maintained proteostasis and inhibited Src-mediated AKT activation to repress mitochondrial OXPHOS in HSCs. Moreover, the glycolytic metabolite, NAD+precursor nicotinamide riboside (NR), accelerated AA catabolism to activate GCN2 and sustain the long-term function of HSCs. Overall, our study uncovered direct links between metabolic alterations and translation control in HSCs during homeostasis and proliferation.


Nature Communications

[IF=17.694]

文獻(xiàn)引用抗體:

bs-12702R-HRP;Anti-phospho-DRP1 (Ser616)/HRP pAb; IHC,IF

bs-0080R;Anti-CD20 pAb; IHC,IF

作者單位:中國(guó)中山大學(xué)中山紀(jì)念醫(yī)院口腔頜面外科

摘要:Mitochondrial dynamics can regulate Major Histocompatibility Complex (MHC)-I antigen expression by cancer cells and their immunogenicity in mice and in patients with malignancies. A crucial role in the mitochondrial fragmentation connection with immunogenicity is played by the IRE1α-XBP-1s axis. XBP-1s is a transcription factor for aminopeptidase TPP2, which inhibits MHC-I complex cell surface expression likely by degrading tumor antigen peptides. Mitochondrial fission inhibition with Mdivi-1 upregulates MHC-I expression on cancer cells and enhances the efficacy of adoptive T cell therapy in patient-derived tumor models. Therefore mitochondrial fission inhibition might provide an approach to enhance the efficacy of T cell-based immunotherapy.


Nature Communications

[IF=17.694]

文獻(xiàn)引用抗體:

bs-2641R;Anti-Integrin alpha 6 pAb; IF

作者單位:美國(guó)俄亥俄州克利夫蘭診所癌癥生物學(xué)

摘要:Therapeutic targeting of angiogenesis in glioblastoma has yielded mixed outcomes. Investigation of tumor-associated angiogenesis has focused on the factors that stimulate the sprouting, migration, and hyperproliferation of the endothelial cells. However, little is known regarding the processes underlying the formation of the tumor-associated vessels. To address this issue, we investigated vessel formation in CD31+ cells isolated from human glioblastoma tumors. The results indicate that overexpression of integrin α3β1 plays a central role in the promotion of tube formation in the tumor-associated endothelial cells in glioblastoma. Blocking α3β1 function reduced sprout and tube formation in the tumor-associated endothelial cells and vessel density in organotypic cultures of glioblastoma. The data further suggest a mechanistic model in which integrin α3β1-promoted calcium influx stimulates macropinocytosis and directed maturation of the macropinosomes in a manner that promotes lysosomal exocytosis during nascent lumen formation. Altogether, our data indicate that integrin α3β1 may be a therapeutic target on the glioblastoma vasculature.


Nature Communications

[IF=17.694]

文獻(xiàn)引用抗體:

bs-4573R;Anti-APOA1 pAb

作者單位:中國(guó)科學(xué)技術(shù)大學(xué)合肥國(guó)家微尺度物理科學(xué)研究中心

摘要:Nanoparticle elasticity is crucial in nanoparticles’ physiological fate, but how this occurs is largely unknown. Using core-shell nanoparticles with a same PEGylated lipid bilayer shell yet cores differing in elasticity (45 kPa – 760 MPa) as models, we isolate the effects of nanoparticle elasticity from those of other physiochemical parameters and, using mouse models, observe a non-monotonic relationship of systemic circulation lifetime versus nanoparticle elasticity. Incubating our nanoparticles in mouse plasma provides protein coronas varying non-monotonically in composition depending on nanoparticle elasticity. Particularly, apolipoprotein A-I (ApoA1) is the only protein whose relative abundance in corona strongly correlates with our nanoparticles’ blood clearance lifetime. Notably, similar results are observed when above nanoparticles’ PEGylated lipid bilayer shell is changed to be non-PEGylated. This work unveils the mechanisms by which nanoparticle elasticity affects nanoparticles’ physiological fate and suggests nanoparticle elasticity as a readily tunable parameter in future rational exploiting of protein corona.


Genome Medicine [IF=15.266]

文獻(xiàn)引用抗體:bs-5720R

Anti-GDF10 pAb; IF

作者單位:希臘瓦里“亞歷山大·弗萊明”生物醫(yī)學(xué)科學(xué)研究中心基礎(chǔ)生物醫(yī)學(xué)研究所

摘要:Background

Synovial fibroblasts (SFs) are specialized cells of the synovium that provide nutrients and lubricants for the proper function of diarthrodial joints. Recent evidence appreciates the contribution of SF heterogeneity in arthritic pathologies. However, the normal SF profiles and the molecular networks that govern the transition from homeostatic to arthritic SF heterogeneity remain poorly defined.

Methods

We applied a combined analysis of single-cell (sc) transcriptomes and epigenomes (scRNA-seq and scATAC-seq) to SFs derived from na?ve and hTNFtg mice (mice that overexpress human TNF, a murine model for rheumatoid arthritis), by employing the Seurat and ArchR packages...


Science Advances [IF=14.957]

文獻(xiàn)引用抗體:

bs-10232RAnti-CD93 pAb

bs-1192R;  Anti-CD14 pAb

作者單位:第四軍醫(yī)大學(xué)口腔醫(yī)學(xué)院口腔頜面外科、軍事口腔醫(yī)學(xué)國(guó)家重點(diǎn)實(shí)驗(yàn)室、國(guó)家口腔疾病臨床研究中心、陜西省口腔醫(yī)學(xué)重點(diǎn)實(shí)驗(yàn)室

摘要:Matching material degradation with host remodeling, including endothelialization and muscular remodeling, is important to vascular regeneration. We fabricated 3D PGS-PCL vascular grafts, which presented tunable polymer components, porosity, mechanical strength, and degrading rate. Furthermore, highly porous structures enabled 3D patterning of conjugated heparin-binding peptide, dimeric thymosin β4 (DTβ4), which played key roles in antiplatelets, fibrinogenesis inhibition, and recruiting circulating progenitor cells, thereafter contributed to high patency rate, and unprecedentedly acquired carotid arterial regeneration in rabbit model. Through single-cell RNA sequencing analysis and cell tracing studies, a subset of endothelial progenitor cells, myeloid-derived CD93+/CD34+ cells, was identified as the main contributor to final endothelium regeneration. To conclude, DTβ4-inspired porous 3DVGs present adjustable physical properties, superior anticoagulating, and re-endothelializing potentials, which leads to the regeneration of small-caliber artery, thus offering a promising tool for vessel replacement in clinical applications.

※ 點(diǎn)擊這里查看往期單月Bioss抗體產(chǎn)品文獻(xiàn)引用列表

版權(quán)所有 2004-2026 www.www.p2b3.cn 北京博奧森生物技術(shù)有限公司
通過(guò)國(guó)際質(zhì)量管理體系ISO 9001:2015 GB/T 19001-2016    證書(shū)編號(hào): 00124Q34771R2M/1100
通過(guò)國(guó)際醫(yī)療器械-質(zhì)量管理體系ISO 13485:2016 GB/T 42061-2022    證書(shū)編號(hào): CQC24QY10047R0M/1100
京ICP備05066980號(hào)-1         京公網(wǎng)安備110107000727號(hào)
罗田县| 永仁县| 九龙坡区| 南汇区| 邯郸县| 安远县| 杭州市| 彝良县| 武强县| 内黄县| 惠水县| 宁夏| 肥东县| 舟山市| 黔东| 繁昌县| 阳山县| 贵德县| 昌宁县| 赣州市| 吉木乃县| 万州区| 沧州市| 鄂托克旗| 金昌市| 灵寿县| 容城县| 耒阳市| 隆安县| 白玉县| 那坡县| 阜新| 遂川县| 永川市| 栾川县| 汉阴县| 敦煌市| 澎湖县| 永兴县| 玉溪市| 榆社县|